SPY—QQQ719.02+0.09%BTC/USD—DIA—GLD—TLT79.52+0.08%
Benzinga
Updated: Oct 19, 2026

Leonid Timashev's Stock Ratings

RBC Capital Analyst

Leonid Timashev is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

8.93%

Smart Score

64.1%

Overall Average Return Percentile

57th

Number of Ratings

100
Buy NowGet Alert
10/15/2026VSTMBuy Now
Verastem
$8.67119.1%$14 → $19MaintainsOutperformGet Alert
10/14/2026RVMDBuy Now
Revolution Medicines
$181.3643.36%$259 → $260MaintainsOutperformGet Alert
10/09/2026KNFBuy Now
Knife River
$49.5816.98%$103 → $58DowngradeOutperform → Sector PerformGet Alert
10/09/2026EXELBuy Now
Exelixis
$62.47-18.36%$45 → $51MaintainsSector PerformGet Alert
10/08/2026RVMDBuy Now
Revolution Medicines
$181.3642.81%$251 → $259MaintainsOutperformGet Alert
10/08/2026LEGNBuy Now
Legend Biotech
$18.54202.05%$58 → $56MaintainsOutperformGet Alert
10/08/2026JAZZBuy Now
Jazz Pharmaceuticals
$208.4342.01%$299 → $296MaintainsOutperformGet Alert
10/08/2026EXELBuy Now
Exelixis
$62.47-27.97%$46 → $45MaintainsSector PerformGet Alert
10/08/2026CYTKBuy Now
Cytokinetics
$63.1179.05%$112 → $113MaintainsOutperformGet Alert
10/08/2026ONCBuy Now
BeOne Medicines
$372.1423.34%$450 → $459MaintainsOutperformGet Alert
10/08/2026AXSMBuy Now
Axsome Therapeutics
$155.9989.11%$297 → $295MaintainsOutperformGet Alert
10/05/2026NAMSBuy Now
NewAmsterdam Pharma Co
$20.81101.83%$50 → $42MaintainsOutperformGet Alert
09/22/2026ALKSBuy Now
Alkermes
$42.9730.32%$56 → $56ReiteratesOutperform → OutperformGet Alert
09/08/2026BHVNBuy Now
Biohaven
$11.3567.4%$23 → $19DowngradeOutperform → Sector PerformGet Alert
08/27/2026RVMDBuy Now
Revolution Medicines
$181.3638.4%$203 → $251MaintainsOutperformGet Alert
08/14/2026CRMDBuy Now
Cormedix
$7.4089.19%$13 → $14MaintainsOutperformGet Alert
08/12/2026LEGNBuy Now
Legend Biotech
$18.54212.84%$59 → $58MaintainsOutperformGet Alert
08/11/2026BHVNBuy Now
Biohaven
$11.35102.64%$22 → $23MaintainsOutperformGet Alert
08/11/2026AXSMBuy Now
Axsome Therapeutics
$155.9990.4%$304 → $297MaintainsOutperformGet Alert
08/07/2026PRAXBuy Now
Praxis Precision Medicine
$260.1777.58%$449 → $462MaintainsOutperformGet Alert
08/07/2026NUVBBuy Now
Nuvation Bio
$4.42352.49%$19 → $20MaintainsOutperformGet Alert
08/07/2026CYTKBuy Now
Cytokinetics
$63.1177.47%$117 → $112MaintainsOutperformGet Alert
08/07/2026CGONBuy Now
CG Oncology
$59.9631.75%$81 → $79MaintainsOutperformGet Alert
08/06/2026XNCRBuy Now
Xencor
$23.19-13.76%$19 → $20MaintainsOutperformGet Alert
08/06/2026RVMDBuy Now
Revolution Medicines
$181.3611.93%$182 → $203MaintainsOutperformGet Alert
08/06/2026NAMSBuy Now
NewAmsterdam Pharma Co
$20.81140.27%$51 → $50MaintainsOutperformGet Alert
08/06/2026CMPSBuy Now
Compass Pathways
$11.0889.56%$22 → $21MaintainsOutperformGet Alert
08/06/2026ONCBuy Now
BeOne Medicines
$372.1420.92%$451 → $450MaintainsOutperformGet Alert
07/27/2026LEGNBuy Now
Legend Biotech
$18.54218.23%$63 → $59MaintainsOutperformGet Alert
07/07/2026VSTMBuy Now
Verastem
$8.6761.44%$15 → $14MaintainsOutperformGet Alert
07/07/2026NUVBBuy Now
Nuvation Bio
$4.42329.86%$20 → $19MaintainsOutperformGet Alert
07/07/2026LEGNBuy Now
Legend Biotech
$18.54239.81%$64 → $63MaintainsOutperformGet Alert
07/07/2026IDYABuy Now
IDEAYA Biosciences
$33.8141.97%$53 → $48MaintainsOutperformGet Alert
07/07/2026EXELBuy Now
Exelixis
$62.47-26.36%$43 → $46MaintainsSector PerformGet Alert
07/07/2026CYTKBuy Now
Cytokinetics
$63.1185.39%$119 → $117MaintainsOutperformGet Alert
07/07/2026CRMDBuy Now
Cormedix
$7.4075.68%$14 → $13MaintainsOutperformGet Alert
07/07/2026ONCBuy Now
BeOne Medicines
$372.1421.19%$436 → $451MaintainsOutperformGet Alert
07/07/2026AXSMBuy Now
Axsome Therapeutics
$155.9994.88%$302 → $304MaintainsOutperformGet Alert
06/30/2026NAMSBuy Now
NewAmsterdam Pharma Co
$20.81145.07%$47 → $51MaintainsOutperformGet Alert
06/18/2026PRAXBuy Now
Praxis Precision Medicine
$260.1772.58% → $449Initiates → OutperformGet Alert
06/17/2026EWTXBuy Now
Edgewise Therapeutics
$37.9255.59%$48 → $59MaintainsOutperformGet Alert
06/09/2026ALKSBuy Now
Alkermes
$42.9730.32%$45 → $56MaintainsOutperformGet Alert
06/05/2026INSMBuy Now
Insmed
$95.29104.64%$205 → $195MaintainsOutperformGet Alert
06/04/2026ADCTBuy Now
ADC Therapeutics
$1.4438.89%$6 → $2DowngradeOutperform → Sector PerformGet Alert
06/02/2026RVMDBuy Now
Revolution Medicines
$181.360.35%$165 → $182MaintainsOutperformGet Alert
06/02/2026EWTXBuy Now
Edgewise Therapeutics
$37.9226.58%$50 → $48MaintainsOutperformGet Alert
06/02/2026ONCBuy Now
BeOne Medicines
$372.1417.16%$425 → $436MaintainsOutperformGet Alert
05/15/2026JSPRBuy Now
Jasper Therapeutics
$0.50502.53%$4 → $3MaintainsSector PerformGet Alert
05/14/2026CMPSBuy Now
Compass Pathways
$11.0898.59%$21 → $22MaintainsOutperformGet Alert
05/13/2026LEGNBuy Now
Legend Biotech
$18.54245.2%$62 → $64MaintainsOutperformGet Alert
05/11/2026CGONBuy Now
CG Oncology
$59.9635.09%$79 → $81MaintainsOutperformGet Alert
05/08/2026INSMBuy Now
Insmed
$95.29115.13%$220 → $205MaintainsOutperformGet Alert
05/07/2026RVMDBuy Now
Revolution Medicines
$181.36-9.02%$162 → $165MaintainsOutperformGet Alert
05/07/2026ONCBuy Now
BeOne Medicines
$372.1414.2%$423 → $425MaintainsOutperformGet Alert
05/06/2026JAZZBuy Now
Jazz Pharmaceuticals
$208.4323.78%$195 → $258MaintainsOutperformGet Alert
05/06/2026CYTKBuy Now
Cytokinetics
$63.1188.56%$101 → $119MaintainsOutperformGet Alert
05/05/2026BRCCBuy Now
BRC
$10.09-75.22%$2.5 → $2.5MaintainsBuyGet Alert
05/05/2026NUVBBuy Now
Nuvation Bio
$4.42352.49%$20 → $20ReiteratesOutperform → OutperformGet Alert
05/05/2026BHVNBuy Now
Biohaven
$11.3593.83%$23 → $22MaintainsOutperformGet Alert
05/05/2026AXSMBuy Now
Axsome Therapeutics
$155.9993.6%$242 → $302MaintainsOutperformGet Alert
05/05/2026ADCTBuy Now
ADC Therapeutics
$1.44316.67%$6 → $6ReiteratesOutperform → OutperformGet Alert
04/28/2026CRMDBuy Now
Cormedix
$7.4089.19%$13 → $14MaintainsOutperformGet Alert
04/27/2026CGONBuy Now
CG Oncology
$59.9631.75%$73 → $79MaintainsOutperformGet Alert
04/14/2026RVMDBuy Now
Revolution Medicines
$181.36-10.67%$140 → $162MaintainsOutperformGet Alert
04/14/2026INSMBuy Now
Insmed
$95.29126.68%$212 → $216MaintainsOutperformGet Alert
04/14/2026IDYABuy Now
IDEAYA Biosciences
$33.8156.76%$49 → $53MaintainsOutperformGet Alert
03/18/2026BCYCBuy Now
Bicycle Therapeutics
$3.5498.02%$11 → $7MaintainsSector PerformGet Alert
03/17/2026CATXBuy Now
Perspective Therapeutics
——$18 → $14MaintainsOutperformGet Alert
03/11/2026LEGNBuy Now
Legend Biotech
$18.54234.41%$66 → $62MaintainsOutperformGet Alert
03/10/2026DSGNBuy Now
Design Therapeutics
$10.6431.58%$13 → $14MaintainsOutperformGet Alert
03/03/2026NUVBBuy Now
Nuvation Bio
$4.42194.12%$12 → $13MaintainsOutperformGet Alert
03/03/2026BHVNBuy Now
Biohaven
$11.35102.64%$22 → $23MaintainsOutperformGet Alert
03/02/2026EXELBuy Now
Exelixis
$62.47-31.17%$46 → $43MaintainsSector PerformGet Alert
02/27/2026ONCBuy Now
BeOne Medicines
$372.1414.2%$417 → $425MaintainsOutperformGet Alert
02/26/2026ALKSBuy Now
Alkermes
$42.974.72%$47 → $45MaintainsOutperformGet Alert
02/25/2026JAZZBuy Now
Jazz Pharmaceuticals
$208.43-6.44%$191 → $195MaintainsOutperformGet Alert
02/24/2026AXSMBuy Now
Axsome Therapeutics
$155.9942.32%$219 → $222MaintainsOutperformGet Alert
02/20/2026CYTKBuy Now
Cytokinetics
$63.1160.04%$95 → $101MaintainsOutperformGet Alert
02/18/2026IDYABuy Now
IDEAYA Biosciences
$33.8144.93%$49 → $49ReiteratesOutperform → OutperformGet Alert
02/18/2026CMPSBuy Now
Compass Pathways
$11.0898.59%$21 → $22MaintainsOutperformGet Alert
02/11/2026EXELBuy Now
Exelixis
$62.47-26.36%$45 → $46MaintainsSector PerformGet Alert
01/23/2026CMPSBuy Now
Compass Pathways
$11.0889.56%$16 → $21MaintainsOutperformGet Alert
01/21/2026IDYABuy Now
IDEAYA Biosciences
$33.8133.1%$41 → $45MaintainsOutperformGet Alert
01/21/2026CYTKBuy Now
Cytokinetics
$63.1150.53%$95 → $95ReiteratesOutperform → OutperformGet Alert
01/21/2026CGONBuy Now
CG Oncology
$59.9621.75%$61 → $73MaintainsOutperformGet Alert
01/21/2026AXSMBuy Now
Axsome Therapeutics
$155.9940.39%$212 → $219MaintainsOutperformGet Alert
01/21/2026NAMSBuy Now
NewAmsterdam Pharma Co
$20.81125.85%$44 → $47MaintainsOutperformGet Alert
01/21/2026NUVBBuy Now
Nuvation Bio
$4.42171.49%$9 → $12MaintainsOutperformGet Alert
01/21/2026CRMDBuy Now
Cormedix
$7.4075.68%$22 → $13MaintainsOutperformGet Alert
01/21/2026RVMDBuy Now
Revolution Medicines
$181.36-22.81%$77 → $140MaintainsOutperformGet Alert
01/21/2026INSMBuy Now
Insmed
$95.29109.89%$197 → $200MaintainsOutperformGet Alert
01/21/2026BHVNBuy Now
Biohaven
$11.3593.83%$9 → $22UpgradeSector Perform → OutperformGet Alert
01/20/2026LEGNBuy Now
Legend Biotech
$18.54255.99%$66 → $66MaintainsOutperformGet Alert
12/22/2025CYTKBuy Now
Cytokinetics
$63.1150.53%$87 → $95MaintainsOutperformGet Alert
12/19/2025PYXSBuy Now
Pyxis Oncology
$1.81175.83%$8 → $5MaintainsOutperformGet Alert
12/18/2025INSMBuy Now
Insmed
$95.29104.64%$215 → $195MaintainsOutperformGet Alert
11/20/2025DSGNBuy Now
Design Therapeutics
$10.6422.18%$6 → $13UpgradeSector Perform → OutperformGet Alert
11/18/2025ONCBuy Now
BeOne Medicines
$372.149.64%$395 → $408MaintainsOutperformGet Alert
11/17/2025JAZZBuy Now
Jazz Pharmaceuticals
$208.43-6.92%$155 → $194MaintainsOutperformGet Alert
11/17/2025CGONBuy Now
CG Oncology
$59.961.73%$53 → $61MaintainsOutperformGet Alert

Recent Analyst Stock Rating News

Jim Cramer Gives Green Light To This Health Care Stock
Jim Cramer Gives Green Light To This Health Care Stock
Cramer warns against Apple Hospitality if rates hit 6%, prefers Vylor over Corteva, backs Jazz, and notes SpaceX may bid for EchoStar.
Cytokinetics Q2 2026 Earnings Call: Complete Transcript
Cytokinetics Q2 2026 Earnings Call: Complete Transcript
On Thursday, Cytokinetics (NASDAQ:CYTK) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial
Insmed Q2 2026 Earnings Call Transcript
Insmed Q2 2026 Earnings Call Transcript
Insmed (NASDAQ:INSM) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings
CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings
CG Oncology Analysts Boost Their Forecasts Following Q1 Earnings
CG Oncology (NASDAQ:CGON) reported mixed results for Q1, with losses of 71 cents per share and sales of $1.083 million. Analysts have adjusted price targets.
Deep Dive Into Nuvation Bio Stock: Analyst Perspectives (7 Ratings)
Deep Dive Into Nuvation Bio Stock: Analyst Perspectives (7 Ratings)
Forecasting The Future: 11 Analyst Projections For Exelixis
Forecasting The Future: 11 Analyst Projections For Exelixis
4 Analysts Have This To Say About Alkermes
4 Analysts Have This To Say About Alkermes
Beyond The Numbers: 11 Analysts Discuss Axsome Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Axsome Therapeutics Stock
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved